Potential benefits of colostrum in gastrointestinal diseases

Frontiers in Bioscience - Scholar

Volumn 8, Issue 2, 2016, Pages 331-351

  Menchetti, Laura ^a   Traina, Giovanna ^a   Tomasello, Giovanni ^b   Casagrande Proietti, Patrizia ^a   Leonardi, Leonardo ^a   Barbato, Olimpia ^c   Brecchia, Gabriele ^c  

^a UNIVERSITY OF PERUGIA   (Italy)

^b IEMEST EuroMediterranean Institute of Science and Technology   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CARBOHYDRATE; COLOSTRININ; CYTOKINE; EPIDERMAL GROWTH FACTOR; GANGLIOSIDE; IMMUNOGLOBULIN; LACTOFERRIN; LYSOZYME; NONSTEROID ANTIINFLAMMATORY AGENT; NUCLEOSIDE; NUCLEOTIDE; OLIGOSACCHARIDE; PLATELET DERIVED GROWTH FACTOR; POLYSACCHARIDE; PROLINE RICH PROTEIN; SOMATOMEDIN B; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN; GLYCOCONJUGATE;

ACUTE DIARRHEA; ARTICLE; BIOCHEMICAL COMPOSITION; BODY COMPOSITION; CANCER CHEMOTHERAPY; CLINICAL TRIAL (TOPIC); COLOSTRUM; DIARRHEA; DRUG INDUCED DISEASE; GASTROINTESTINAL DISEASE; HELICOBACTER INFECTION; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFECTIOUS DIARRHEA; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; NECROTIZING ENTEROCOLITIS; NONHUMAN; SHORT BOWEL SYNDROME; SUPPLEMENTATION; TREATMENT CONTRAINDICATION; TREATMENT DURATION; ANIMAL; BOVINE; CHEMISTRY; DIETARY SUPPLEMENT; FEMALE; GASTROINTESTINAL DISEASES; ACUTE DISEASE; CHEMOTHERAPY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

ANIMALS; CATTLE; COLOSTRUM; DIETARY SUPPLEMENTS; FEMALE; GASTROINTESTINAL DISEASES; HUMANS;

EID: 84988922874     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s467     Document Type: Article

References (191)

1. P Langer: Differences in the Composition of Colostrum and Milk in Eutherians Reflect Differences in Immunoglobulin Transfer. J Mammal 90 (2), 332-9 (2009) DOI: 10.1644/08-MAMM-A-071.1.
2. RL Shen, T Thymann, MV Østergaard, AC Støy, Ł Krych, DS Nielsen, C Lauridsen, B Hartmann, JJ Holst, DG Burrin, PT Sangild: Early gradual feeding with bovine colostrum improves gut function and NEC resistance relative to infant formula in preterm pigs. Am J Physiol Gastrointest Liver Physiol 309 (5), 310-23 (2015) DOI: 10.1152/ajpgi.00163.2015.
3. B Lonnerdal: Bioactive proteins in breast milk. J Paediatr Child Health 49 (Suppl1), 1-7 (2013) DOI: 10.1111/jpc.12104.
4. SI Kehoe, BM Jayarao, AJ Heinrichs: A survey of bovine colostrum composition and colostrum management pratictices on Pennsylvania diry farms. J Dairy Sci 90 (9), 4108-16 (2007) DOI: 10.3168/jds.2007-0040.
5. K Stelwagen, E Carpenter, B Haigh, A Hodgkinson, TT Wheeler: Immune components of bovine colostrum and milk. J Anim Sci 87 (Suppl13), 3-9 (2009) DOI: 10.2527/jas.2008-1377.
6. KF Benson, SG Carter, KM Patterson, D Patel, GS Jensen: A novel extract from bovine colostrum whey supports anti-bacterial and anti-viral innate immune functions in vitro and in vivo I. Enhanced immune activity in vitro translates to improved microbial clearance in animal infection models. Prev Med 54, 116-23 (2011) DOI: 10.1016/j.ypmed.2011.12.023.
7. RM Lawrence, CA Pane: Human breast milk: current concepts of immunology and infectious diseases. Curr Probl Pediatr Adolesc Health Care 37 (1), 7-37 (2007) DOI: 10.1016/j.cppeds.2006.10.002.
8. TT Wheeler, AJ Hodgkinson, CG Prosser, SR Davis: Immune components of colostrums and milk: A historical perspective. J Mammary Gland Biol Neoplasia 12 (4), 237-47 (2007) DOI: 10.1007/s10911-007-9051-7.
9. M Janusz, A Zabłocka: Colostrinin: A proline-rich polypeptide complex of potential therapeutic interest. Cell Mol Biol 59 (1), 4-11 (2013) doi not found.
10. RJ Playford: Peptide therapy and the gastroenterologist: colostrum and milk-derived growth factors. Clin Nutr 20 (Suppl1), 101-6 (2001) DOI: 10.1054/clnu.2001.0434.
11. KS Kelly: Bovine colostrums: A review of clinical uses. Altern Med Rev 8 (4), 378-94 (2004) doi not found.
12. H Li, RE Aluko: Bovine colostrum as a bioactive product against human microbial infections and gastrointestinal disorders. Curr Top Nutraceutical Res 4 (3-4), 227-37 (2006) doi not found.
13. L Elfstrand, H Lindmark-Månsson, M Paulssona, L Nybergc, B Akesson: Immunoglobulins, growth factors and growth hormone in bovine colostrum and the effects of processing. Int Dairy J 12 (11), 879-87 (2002) DOI: 10.1016/S0958-6946(02)00089-4.
14. M Moore, WJ Tyler, M Chigerwe, ME Dawes, JR Middleton: Effect of delayed colostrum collection on colostral IgG concentration in dairy cows. J Am Vet Med Assoc 226 (8), 1375-7 (2005) DOI: 10.2460/javma.2005.226.1375.
15. AK Dang, S Kapila, MPC Singh: Changes in colostrum of Murrah buffaloes after calving. Trop Anim Health Prod 41 (7), 1213-7 (2009) DOI: 10.1007/s11250-008-9302-7.
16. H Korhonen, A Pihlanto: Technological options for the production of health-promoting proteins and peptides derived from milk and colostrums. Curr Pharm Des 13 (8), 829-43 (2007) DOI: 10.2174/138161207780363112.
17. BL Larson, HL Jr Heary, JE Devery: Immunoglobulin production and transport by the mammary gland. J Dairy Sci 63 (4), 665-71 (1980) DOI: 10.3168/jds.S0022-0302(80)82988-2.
18. EM Lilius, P. Marnila: The role of colostral antibodies in prevention of microbial infections. Curr Opin Infect Dis 14 (3), 295-300 (2001) DOI: 10.1097/00001432-200106000-00008.
19. R Mehra, P Marnila, H Korhonen: Milk immunoglobulins for health promotion. Int Dairy J 16 (11), 1262-71 (2006) DOI: 10.1016/j.idairyj.2006.06.003.
20. JK Sponseller, JA Steele, DJ Schmidt, HB Kim, G Beamer, X Sun, S Tzipori: Hyperimmune Bovine Colostrum as a Novel Therapy to Combat Clostridium difficile Infection. J Infect Dis 211 (8), 1334-41 (2015) DOI: 10.1093/infdis/jiu605.
21. S Hiss, T Meyer, H Sauerwein: Lactoferrin concentrations in goat milk throughout lactation. Small Rumin Res 80 (1-3), 87-90 (2008) DOI: 10.1016/j.smallrumres.2008.07.027.
22. D Legrand, E Elass, M Carpentier, J Mazurier: Lactoferrin: A modulator of immune and inflammatory responses. Cell Nol Life Sci 62 (22), 2549-59 (2005) DOI: 10.1007/s00018-005-5370-2.
23. N Anand, RK Kanwar, ML Dubey, RK Vahishta, R Sehgal, AK Verma, JR Kanwar: Effect of lactoferrin protein on red blood cells and macrophages: mechanism of parasite-host interaction. Drug Des Devel Ther 9, 821-35 (2015) doi not found.
24. MM Rahman, WS Kim, T Ito, H Kumura, K Shimazaki: Growth promotion and cell binding ability of bovine lactoferrin to Bifidobacterium longum. Anaerobe 15 (4), 133-7 (2009) DOI: 10.1016/j.anaerobe.2009.01.003.
25. V Buccigrossi, G de Marco, E Bruzzese, Ombrato L, I Bracale, G Polito, Guarino A: Lactoferrin induces concentration-dependent functional modulation of intestinal proliferation and differentiation. Pediatr Res 61 (4), 410-4 (2007) DOI: 10.1203/pdr.0b013e3180332c8d.
26. J Artym, M Zimecki: Milk-derived proteins and peptides in clinical trials. Postepy Hig Med Dosw (Online) 67, 800-16 (2013) DOI: 10.5604/17322693.1061635.
27. J Przybylska, E Albera, M Kankofer: Antioxidants in bovine colostrum. Reprod Domest Anim 42 (4), 402-9 (2007) DOI: 10.1111/j.1439-0531.2006.00799.x.
28. L Ahmed, SK Nazul Islam, MNI Khan, S Huque, M Ashan: Antioxidant micronutrient profile (vitamin E, C, A, Cooper, Zinc, Iron) of colostrums: Association with maternal characteristics. J Trop Pediatr 50 (6), 357-8 (2004) DOI: 10.1093/tropej/50.6.357.
29. A Belo, T Marchbank, A Fitzgerald, S Ghosh, RJ Playford: Gastroprotective effects of oral nucleotide administration. Gut 55 (2), 165-71 (2006) DOI: 10.1136/gut.2005.076752.
30. WH Yu: Scientific rationale and benefits of nucleotide supplementation of infant formula. J Paediatr Child Health 38 (6), 543-9 (2002) DOI: 10.1046/j.1440-1754.2002.00056.x.
31. XL Pan, T Izumi: Variation of the ganglioside compositions of human milk, cow's milk and infant formulas. Early Hum Dev 57 (1), 25-31 (2000) DOI: 10.1016/S0378-3782(99)00051-1.
32. R Rueda: The role of dietary gangliosides on immunity and the prevention of infection. Br J Nutr 98 (Suppl1), 68-73 (2007) DOI: 10.1017/S0007114507832946.
33. T Idot, H Kawakami: Inhibitory effects of milk gangliosides on the adhesion of escherichia coli to human intestinal carcinoma cells. Biosci Biotech Biochem 59 (1), 69-72 (1995) DOI: 10.1271/bbb.59.69.
34. T Nakano, M Sugawara, H Kawakami: Sialic acid in human milk: composition and functions. Acta Paediatr Taiwan 42 (1), 11-7 (2001) doi not found.
35. T Urashima, E Taufik, K Fukuda, S Asakuma: Recent advances in studies on milk oligosaccharides of cows and other domestic farm animals. Biosci Biotechnol Biochem 77 (3), 455-66 (2013) DOI: 10.1271/bbb.120810.
36. T Urashima, K Fukuda, M Messer: Evolution of milk oligosaccharides and lactose: A hypothesis. Animal 6 (3), 369-74 (2012) DOI: 10.1017/S1751731111001248.
37. DS Newburg: Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. J Anim Sci 87 (Suppl13), 26-34 (2009) DOI: 10.2527/jas.2008-1347.
38. H Tlaskalová-Hogenová, R Štepánková, T Hudcovic, L Tucková, B Cukrowska, R Lodinová-Žádniková: Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett 93, (2-3), 97-108 (2004) DOI: 10.1016/j.imlet.2004.02.005.
39. S Jara, M Sánchez, R Vera, J Cofré, E Castro: The inhibitory activity of Lactobacillus spp. isolated from breast milk on gastrointestinal pathogenic bacteria of nosocomial origin. Anaerobe 17 (6), 474-7 (2011) DOI: 10.1016/j.anaerobe.2011.07.008.
40. A Sokolowska, R Bednarz, M Pacewicz, JA Georgiades, T Wilusz, A Polanowski: Colostrum from different mammalian species-A rich source of colostrinin. Int Dairy J 18 (2), 204-9 (2008) DOI: 10.1016/j.idairyj.2007.08.004.
41. M Janusz, J Lisowski: Proline-rich polypeptide (PRP)-An immunomodulatory peptide from bovine colostrums. Arch Immun Et Ther Exper 41 (5-6), 275-9 (1993) doi not found.
42. I Boldogh, L Aguilera-Aguirre, A Bacsi, BK Choudhury, A Saavedra-Molina, M Kruzel: Colostrin decreases hypersensitivity and allergic responses to common allergens. Int Arch Allergy Immunol 146 (4), 298-306 (2008) DOI: 10.1159/000121464.
43. MG Stewart: New insight into mode of action of Colostrinin. J Nutr Health Aging 14 (4), 336 (2010) DOI: 10.1007/s12603-010-0076-z.
44. A Zabłocka, A Ogorzałek, J Macała, M Janusz: A proline-rich polypeptide complex (PRP) influences inducible nitric oxide synthase in mice at the protein level. Nitric Oxide 23 (1), 20-5 (2010) DOI: 10.1016/j.niox.2010.03.003.
45. M Janusz, A Zabłocka: Colostral proline-rich polypeptides-immunoregulatory properties and prospects of therapeutic use in Alzheimer's disease. Curr Alzheimer Res 7 (4), 323-33 (2010) DOI: 10.2174/156720510791162377.
46. A Bacsi, GJ Stanton, TK Hughes, M Kruzel, I Boldogh: Colostrinin-driven neurite outgrowth requires p53 activation in PC12 cells. Cell Mol Neurobiol 25 (7), 1123-39 (2005) DOI: 10.1007/s10571-005-8222-6.
47. DA Camfield, L Owen, AB Scholey, A Pipingas, C Stough: Dairy constituents and neurocognitive health in ageing. Br J Nutr 106 (2), 159-74 (2011) DOI: 10.1017/S0007114511000158.
48. R Garofalo: Cytokines in human milk. J Pediatr 156 (Suppl2), 36-40 (2010) DOI: 10.1016/j.jpeds.2009.11.019.
49. K Hagiwara, S Kataoka, H Yamanaka, R Kirisawa, H Iwai: Detection of cytokines in bovine colostrums. Vet Immunol Immunopathol 76 (3-4), 183-90 (2000) DOI: 10.1016/S0165-2427(00)00213-0.
50. MM Sira, T Yoshida, M Takeuchi, Y Kashiwayama, T Futatani, H Kanegane, A Sasahara, Y Ito, M Mizuguchi, T Imanaka, T Miyawaki: A novel immunoregulatory protein in human colostrum, syntenin-1, for promoting the development of IgA-producing cells from cord blood B cells. Int Immunol 21 (9), 1013-23 (2009) DOI: 10.1093/intimm/dxp067.
51. CM Shing, JM Peake, K Suzuki, DG Jenkins, JS Coombes: Bovine colostrum modulates cytokine production in human peripheral blood mononuclear cells stimulated with lipopolysaccharide and phytohemagglutinin. J Interferon Cytokine Res 29 (1), 37-44 (2009) DOI: 10.1089/jir.2008.0015.
52. DC Donovan, AJ Reber, J Gabbard, M Aceves-Avila, KL Galland, K Holbert, LO Ely, DJ Hurley: Effect of maternal cells transferred with colostrum on cellular responses to pathogen antigens in neonatal calves. Am J Vet Res 68 (7), 778-82 (2007) DOI: 10.2460/ajvr.68.7.778.
53. AJ Reber, DC Donovan, J Gabbard, K Galland, M Aceves-Avila, KA Holbert, L Marshall, DJ Hurley: Transfer of maternal colostral leukocytes promotes development of the neonatal immune system I. Effects on monocyte lineage cells. Vet Immunol Immunopathol 123 (3-4), 186-96 (2008) DOI: 10.1016/j.vetimm.2008.01.034.
54. JF Kuemmerle: Insulin-like growth factors in the gastrointestinal tract and liver. Endocrinol Metab Clin North Am 41 (2), 409-23 (2012) DOI: 10.1016/j.ecl.2012.04.018.
55. JW Blum, CR Baumrucker: Colostral insulin-like growth factors and related substances: mammary gland, and neonatal (intestinal and systemic) targets. Domest Anim Endocrinol 23 (1-2), 101-10 (2002) DOI: 10.1016/S0739-7240(02)00149-2.
56. PM Jehle, RD Fussgaenger, WF Blum, NK Angelus, A Hoeflich, E Wolf, RJ Jungwirth: Differential autocrine regulation of intestinal epithelial cell proliferation and differentiation by insulin-like growth factor (IGF) system component. Horm Metab Res 31 (2-3), 97-102 (1999) DOI: 10.1055/s-2007-978705.
57. M Good, CP Sodhi, CE Egan, A Afrazi, H Jia, Y Yamaguchi, P Lu, MF Branca, C Ma, T Jr Prindle, S Mielo, A Pompa, Z Hodzic, JA Ozolek, DJ Hackam: Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptor. Mucosal Immunol 8 (5), 1166-79 (2015) DOI10.1038/mi.2015.30.
58. JF Thompson, M Van Den Berg, PCF Stokkers: Developmental regulation of epidermal growth factor receptor kinase in rat intestine. Gastroenterology 107 (5), 1278-87 (1994) DOI: 10.1016/0016-5085(94)90528-2.
59. H Okuyama, M Urao, D Lee, RA Drongowski, AG Coran: The effect of epidermal growth factor on bacterial translocation in newborn rabbits. J Pediatr Surg 33 (2), 225-8 (1998) DOI: 10.1016/S0022-3468(98)90436-5.
60. SA Cartlidge, JB Elder: Transforming growth factor α and EGF levels in normal human gastrointestinal mucosa. Br J Cancer 60 (5), 657-60 (1989) DOI: 10.1038/bjc.1989.334.
61. S Koyama, DK Podolsky: Differential expression of transforming growth factors α and β in rat intestinal epithelial cells. J Clin Invest 83 (5), 1768-73 (1989) DOI: 10.1172/JCI114080.
62. DN Nguyen, PT Sangild, MV Ostergaard, SB Bering, DE Chatterton: Transforming growth factor-β2 and endotoxin interact to regulate homeostasis via interleukin-8 levels in the immature intestine. Am J Physiol Gastrointest Liver Physiol 307 (7), 689-99 (2014) DOI: 10.1152/ajpgi.00193.2014.
63. J Ogawa, A Sasahara, T Yoshida, MM Sira, T Futatani, H Kanegane, T Miyawaki: Role of transforming growth factor-beta in breast milk for initiation of IgA production in newborn infants. Early Hum Dev 77 (1-2), 67-75 (2004) DOI: 10.1016/j.earlhumdev.2004.01.005.
64. YW Shing, M Klagsbrun: Human and bovine milk contain different sets of growth factors. Endocrinology 115 (1), 273-82 (1984) DOI: 10.1210/endo-115-1-273.
65. PJ Keck, SD Hauser, G Krivi, K Sanzo, T Warren, J Feder, DT Connolly: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246 (4935), 1309-12 (1989) DOI: 10.1126/science.2479987.
66. CG Siafakas, F Anatolitou, RD Fusunyan, WA Walker, IR Sanderson: Vascular endothelial growth factor (VEGF) is present in human breast milk and its receptor is present on intestinal epithelial cells. Pediatr Res 45 (5 Pt1), 652-7 (1999) DOI: 10.1203/00006450-199905010-00007.
67. P Rawal, V Gupta, BR Thapa: Role of colostrum in gastrointestinal infections. Indian J Pediatr 75 (9), 917-21 (2008) DOI: 10.1007/s12098-008-0192-5.
68. RJ Playford, CE Macdonald, WS Johnson: Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders. Am J Clin Nutr 72 (1), 5-14 (2000) doi not found.
69. BR Thapa: Therapeutic potentials of bovine colostrums. Indian J Pediatr 72 (10), 849-52 (2005) DOI: 10.1007/BF02731112.
70. M Blais, M Fortier, Y Pouliot, SF Gauthier, Y Boutin, C Asselin, M Lessard: Colostrum whey down-regulates the expression of early and late inflammatory response genes induced by Escherichia coli and Salmonella enterica Typhimurium components in intestinal epithelial cells. Br J Nutr 113 (2), 200-11 (2014) DOI: 10.1017/S0007114514003481.
71. I Shibata, M Ono, M Mori: Passive protection against porcine epidemic diarrhea (PED) virus in piglets by colostrum from immunized cows. J Vet Med Sci 63 (6), 655-8 (2001) DOI: 10.1292/jvms.63.655.
72. G Günaydin, R Zhang, L Hammarström, H Marcotte: Engineered Lactobacillus rhamnosus GG expressing IgG-binding domains of protein G: Capture of hyperimmune bovine colostrum antibodies and protection against diarrhoea in a mouse pup rotavirus infection model. Vaccine 32 (4), 470-7 (2014) DOI: 10.1016/j.vaccine.2013.11.057.
73. M Inagaki, H Muranishi, K Yamada, K Kakehi, K Uchida, T Suzuki, T Yabe, T Nakagomi, O Nakagomi, Y Kanamaru: Bovine κ-casein inhibits human rotavirus (HRV) infection via direct binding of glycans to HRV. J Dairy Sci 97 (5), 2653-61 (2014) DOI: 10.3168/jds.2013-7792.
74. M Inagaki, M Yamamoto, Cairangzhuoma Xijier, T Yabe, K Uchida, M Kawasaki, T Nakagomi, O Nakagomi, N Minamoto, Y Kanamaru: Multiple-dose therapy with bovine colostrum confers significant protection against diarrhea in a mouse model of human rotavirus-induced gastrointestinal disease. J Dairy Sci 96 (2), 806-14 (2013) DOI: 10.3168/jds.2012-5847.
75. AK Mitra, D Mahalanabis, H Ashraf, L Unicomb, R Eeckels, S Tzipori: Hyperimmune cow colostrum reduces diarrhoea due to rotavirus: A double-blind, controlled clinical trial. Acta Paediatr 84 (9), 996-1001 (1995) DOI: 10.1111/j.1651-2227.1995.tb13814.x.
76. GP Davidson, PB Whyte, E Daniels, K Franklin, H Nunan, PI McCloud, AG Moore, DJ Moore: Passive immunization of children with bovine colostrum containing antibodies to human rotavirus. Lancet 2 (8665), 709-12 (1989) DOI: 10.1016/S0140-6736(89)90771-X.
77. RB Turner, DK Kelsey: Passive immunization for prevention of rotavirus illness in healthy infants. Pediatr Infect Dis J 12 (9), 718-22 (1993) DOI: 10.1097/00006454-199309000-00003.
78. H Hilpert, H Brüssow, C Mietens, J Sidoti, L Lerner, H Werchau: Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants. J Infect Dis 156 (1), 158-66 (1987) DOI: 10.1093/infdis/156.1.158.
79. D Durand, TJ Ochoa, SM Bellomo, CA Contreras, VH Bustamante, J Ruiz, TG Cleary: Detection of secretory immunoglobulin A in human colostrum as mucosal immune response against proteins of the type III secretion system of Salmonella, Shigella and enteropathogenic Escherichia coli. Pediatr Infect Dis J 32 (10), 1122-6 (2013) DOI: 10.1097/INF.0b013e318293306c.
80. W Otto, B Najnigier, T Stelmasiak, RM Robins- Browne: Randomized control trials using a tablet formulation of hyperimmune bovine colostrum to prevent diarrhea caused by enterotoxigenic Escherichia coli in volunteers. Scand J Gastroenterol 46 (7-8), 862-8 (2011) DOI: 10.3109/00365521.2011.574726.
81. CP Champagne, Y Raymond, Y Pouliot, SF Gauthier, M Lessard: Effect of bovine colostrum, cheese whey, and spray-dried porcine plasma on the in vitro growth of probiotic bacteria and Escherichia coli. Can J Microbiol 60 (5), 287-95 (2014) DOI: 10.1139/cjm-2014-0130.
82. DA Vilte, M Larzábal, AA Cataldi, EC Mercado: Bovine colostrum contains immunoglobulin G antibodies against intimin, EspA, and EspB and inhibits hemolytic activity mediated by the type three secretion system of attaching and effacing Escherichia coli. Clin Vaccine Immunol 15 (8), 1208-13 (2008) DOI: 10.1128/CVI.00027-08.
83. S Sugiharto, AS Poulsen, N Canibe, C Lauridsen: Effect of bovine colostrum feeding in comparison with milk replacer and natural feeding on the immune responses and colonisation of enterotoxigenic Escherichia coli in the intestinal tissue of piglets. Br J Nutr 113 (6), 923-34 (2015) DOI: 10.1017/S0007114514003201.
84. HI Tawfeek, NH Najim, S Al-Mashikhi: Efficacy of an infant formula containing anti- Escherichia coli colostral antibodies from hyperimmunized cows in preventing diarrhea in infants and children: A field trial. Int J Infect Dis 7 (2), 120-8 (2003) DOI: 10.1016/S1201-9712(03)90007-5.
85. CO Tacket, G Losonsky, H Link, Y Hoang, P Guesry, H Hilpert, MM Levine: Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli. N Engl J Med 318 (19), 1240-3 (1988) DOI: 10.1056/NEJM198805123181904.
86. DJ Freedman, CO Tacket, A Delehanty, DR Maneval, J Nataro, JH Crabb: Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli. J Infect Dis 177 (3), 662-7 (1998) DOI: 10.1086/514227.
87. DM Lyerly, EF Bostwick, SB Binion, TD Wilkins: Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate. Infect Immun 59 (6), 2215-8 (1991) doi not found.
88. E Mattila, VJ Anttila, M Broas, H Marttila, P Poukka, K Kuusisto, L Pusa, K Sammalkorpi, J Dabek, OP Koivurova, M Vähätalo, V Moilanen, T Widenius: A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-Associated diarrhoea: efficacy and safety data of a prematurely interrupted trial. Scand J Infect Dis 40 (9), 702-8 (2008) DOI: 10.1080/00365540801964960.
89. P Naaber, E Lehto, S Salminen, M Mikelsaar: Inhibition of adhesion of Clostridium difficile to Caco-2 cells. FEMS Immunol Med Microbiol 14 (4), 205-9 (1996) DOI: 10.1111/j.1574-695X.1996.tb00288.x.
90. C Akisu, U Aksoy, H Cetin, S Ustun, M Akisu: Effect of human milk and colostrum on Entamoeba histolytica. World J Gastroenterol 10 (5), 741-742 (2004) DOI: 10.3748/wjg.v10.i5.741.
91. PC Okhuysen, CL Chappell, J Crabb, LM Valdez, ET Douglass, HL DuPont: Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum. Clin Infect Dis 26 (6), 1324-29 (1998) DOI: 10.1086/516374.
92. S Tzipori, D Roberton, DA Cooper, L White: Chronic cryptosporidial diarrhoea and hyperimmune cow colostrums. Lancet 2 (8554), 344-5 (1987) DOI: 10.1016/S0140-6736(87)90944-5.
93. PD Greenberg, JP Cello: Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 13 (4), 348-54 (1996) DOI: 10.1097/00042560-199612010-00008.
94. S Purup, MO Vestergaard, L Pedersen, K Sejrsen: Biological activity of bovine milk on proliferation of human intestinal cells. J Dairy Res 74 (1), 58-65 (2007) DOI: 10.1017/S0022029906002093.
95. KS Chattha, AN Vlasova, S Kandasamy, MA Esseili, C Siegismund, G Rajashekara, LJ Saif: Probiotics and colostrum/milk differentially affect neonatal humoral immune responses to oral rotavirus vaccine. Vaccine 31 (15), 1916-23 (2013) DOI: 10.1016/j.vaccine.2013.02.020.
96. XH Huang, L Chen, W Gao, W Zhang, SJ Chen, LB Xu, SQ Zhang: Specific IgG activity of bovine immune milk against diarrhea bacteria and its protective effects on pathogen-infected intestinal damages. Vaccine 26 (47), 5973-5980 (2008) DOI: 10.1016/j.vaccine.2008.08.040.
97. J Seifert, M Molkewehrum, S Oesser, L Nebermann, C Schulze: Endotoxin inactivation by enterally applied colostrum of different composition. Eur Surg Res 34 (1-2), 68-72 (2002) DOI: 10.1159/000048890.
98. EB Wong, JF Mallet, J Duarte, C Matar, BW Ritz: Bovine colostrum enhances natural killer cell activity and immune response in a mouse model of influenza infection and mediates intestinal immunity through toll-like receptors 2 and 4. Nutr Res 34 (4), 318-25 (2014) DOI10.1016/j.nutres.2014.02.007.
99. MJ An, JH Cheon, SW Kim, JJ Park, CM Moon, SY Han, ES Kim, TI Kim, WH Kim: Bovine colostrum inhibits nuclear factor kappa B-mediated proinflammatory cytokine expression in intestinal epithelial cells. Nutr Res 29 (4), 275-80 (2009) DOI: 10.1016/j.nutres.2009.03.011.
100. D Cardani: COLOSTRO NONI administration effects on epithelial cells turn-over, inflammatory events and integrity of intestinal mucosa junctional systems. Minerva Gastroenterol Dietol 60 (1), 71-8 (2014) doi not found.
101. R Neiger, KW Simpson: Helicobacter infection in dogs and cats: Facts and fiction. J Vet Intern Med 14 (2), 125-133 (2000) DOI: 10.1892/0891-6640(2000)014<0125:IIDACF>2.3.CO;2.
102. AA Dos Santos, AA Carvalho: Pharmacological therapy used in the elimination of Helicobacter pylori infection: A review. World J Gastroenterol 21 (1), 139-154 (2015) DOI: 10.3748/wjg.v21.i1.139.
103. P Marnila, S Rokka, L Rehnberg-Laiho, P Kärkkäinen, TU Kosunen, H Rautelin, ML Hänninen, EL Syväoja, H Korhonen: Prevention and suppression of Helicobacter felis infection in mice using colostral preparation with specific antibodies. Helicobacter 8 (3), 192-201 (2003) DOI: 10.1046/j.1523-5378.2003.00144.x.
104. CD Tran, S Kritas, MA Campbell, HQ Huynh, SS Lee, RN Butler: Novel combination therapy for the eradication of Helicobacter pylori infection in a mouse model. Scand J Gastroenterol 45 (12), 1424-30 (2010) DOI: 10.3109/00365521.2010.506245.
105. MM Bitzan, BD Gold, DJ Philpott, M Huesca, PM Sherman, H Karch, R Lissner, CA Lingwood, MA Karmali: Inhibition of Helicobacter pylori and Helicobacter mustelae binding to lipid receptors by bovine colostrums. J Infect Dis 177 (4), 955-61 (1998) DOI: 10.1086/515256.
106. S Rokka, S Myllykangas, V Joutsjoki: Effect of specific colostral antibodies and selected lactobacilli on the adhesion of Helicobacter pylori on AGS cells and the Helicobacter-induced IL-8 production. Scand J Immunol 68 (3), 280-6 (2008) DOI: 10.1111/j.1365-3083.2008.02138.x.
107. TH Casswall, HO Nilsson, L Björck, S Sjöstedt, L Xu, CK Nord, T Borén, T Wadström, L Hammarström: Bovine anti-Helicobacter pylori antibodies for oral immunotherapy. Scand J Gastroenterol 37 (12), 1380-5 (2002) DOI: 10.1080/003655202762671242.
108. ML Xu, HJ Kim, HJ Kim: Effect of dietary bovine colostrum on the responses of immune cells to stimulation with bacterial lipopolysaccharide. Arch Pharm Res 37 (4), 494-500 (2014) DOI: 10.1007/s12272-013-0255-7.
109. S Tarpila, H Korhonen, S Salminen: Immune Colostrums in the Treatment of Helicobacter Pylori Gastritis. In: Abstract book of 24th International Dairy Congress, Melbourne, Australia, 293 (1995).
110. M Oona, T Rago, HI Maaroos: Helicobacter pylori in children with abdominal complaints: has immune colostrum some influence on gastritis? Alpe Adria Microbiology J 6, 49-57 (1997).
111. AR Opekun, HM El-Zaimaity, MS Osato, MA Gilger, HM Malaty, M Terry, DR Headon, DY Graham: Novel therapies for Helicobacter pylori infection. Aliment Pharmacol Ther 13 (1), 35-42 (1999) DOI: 10.1046/j.1365-2036.1999.00435.x.
112. TH Casswall, SA Sarker, MJ Albert, GJ Fuchs, M Bergström, L Björck, L Hammarström: Treatment of Helicobacter pylori infection in infants in rural Bangladesh with oral immunoglobulins from hyperimmune bovine colostrum. Aliment Pharmacol Ther 12 (6), 563-8 (1998) DOI: 10.1046/j.1365-2036.1998.00335.x.
113. J Steele, J Sponseller, D Schmidt, O Cohen, S Tzipori: Hyperimmune bovine colostrum for treatment of GI infections: A review and update on Clostridium difficile. Hum Vaccin Immunother 9 (7), 1565-8 (2013) DOI: 10.4161/hv.24078.
114. ST Sonis: The pathobiology of mucositis. Nat Rev Cancer 4 (4), 277-84 (2004) DOI: 10.1038/nrc1318.
115. MJ van Vliet, WJ Tissing, CA Dun, NE Meessen, WA Kamps, ES de Bont, HJ Harmsen: Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin Infect Dis 49 (2), 262-70 (2009) DOI: 10.1086/599346.
116. AM Stringer, RJ Gibson, JM Bowen, RM Logan, K Ashton, AS Yeoh, N Al-Dasooqi, DM Keefe: Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile. Int J Exp Pathol 90 (5), 489-99 (2009) DOI: 10.1111/j.1365-2613.2009.00671.x.
117. GS Howarth, GL Francis, JC Cool, RW Ballard, LC Read: Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats. J Nutr 126 (10), 2519-30 (1996) doi not found.
118. HY Chen, O Mollstedt, MH Tsai, RB Kreider: Potential clinical applications of multi-functional milk proteins and peptides in cancer management. Curr Med Chem 21 (21), 2424-37 (2014) DOI: 10.2174/0929867321666140205135739.
119. PE Pontoppidan, RL Shen, MS Cilieborg, P Jiang, H Kissow, BL Petersen, T Thymann, C Heilmann, K Müller, PT Sangild: Bovine Colostrum Modulates Myeloablative Chemotherapy-Induced Gut Toxicity in Piglets. J Nutr 145 (7), 1472-80 (2015) DOI: 10.3945/jn.114.203430.
120. ST Sonis, L Lindquist, A Van Vugt, AA Stewart, K Stam, GY Qu, KK Iwata, JD Haley: Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor beta 3. Cancer Res 54 (5), 1135-8 (1994) doi not found.
121. GS Howarth, JC Cool, AJ Bourne, FJ Ballard, LC Read: Insulin-like growth factor-I (IGF-I) stimulates regrowth of the damaged intestine in rats, when administered following, but not concurrent with, methotrexate. Growth Factors 15 (4), 279-292 (1998) DOI: 10.3109/08977199809017483.
122. NM Gordler, M McGurk, S Aqual, M Prince: The effect of epidermal growth factor mouthwash on cytotoxic-induced oral ulceration. Am J Clin Oncol 18 (5), 403-6 (1995) DOI: 10.1097/00000421-199510000-00009.
123. DS Newburg, WA Walker: Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr Res 61 (1), 2-8 (2007) DOI: 10.1203/01.pdr.0000250274.68571.18.
124. M Cairangzhuoma, H Yamamoto, H Muranishi, M Inagaki, K Uchida, K Yamashita, S Saito, T Yabe, Y Kanamaru: Skimmed, sterilized, and concentrated bovine late colostrum promotes both prevention and recovery from intestinal tissue damage in mice. J Dairy Sci 96 (3), 1347-55 (2013) DOI: 10.3168/jds.2012-5701.
125. AB Yaacov, Y Lichtenstein, L Zolotarov, Y Ilan: The gut microbiome as a target for regulatory T cell-based immunotherapy: induction of regulatory lymphocytes by oral administration of anti-LPS enriched colostrum alleviates immune mediated colitis. BMC Gastroenterol 15 (1), 154-61 (2015) DOI: 10.1186/s12876-015-0388-x.
126. J Martin, SC Howard, A Pillai, P Vogel, AP Naren, S Davis, K Ringwald-Smith, K Buddington, RK Buddington: The weaned pig as a model for Doxorubicin-induced mucositis. Chemotherapy 60 (1), 24-36 (2014) DOI: 10.1159/000365725.
127. L Trepanier: Drug Interactions and Differential Toxicity of NSAIDs. In: ACVIM Proceedings (2002) doi not found.
128. UA Boelsterli, MR Redinbo, KS Saitta: Multiple NSAID-induced hits injure the small intestine: underlying mechanisms and novel strategies. Toxicol Sci 131 (2), 654-67 (2013) DOI: 10.1093/toxsci/kfs310.
129. M Hagiwara, K Kataoka, H Arimochi, T Kuwahara, Y Ohnishi: Role of unbalanced growth of gram-negative bacteria in ileal ulcer formation in rats treated with a nonsteroidal anti-inflammatory drug. J Med Invest 51 (1-2), 43-51 (2004) DOI: 10.2152/jmi.51.43.
130. RD Berg: Bacterial translocation from the gastrointestinal tract. Adv Exp Med Biol 473, 11-30 (1999) DOI: 10.1007/978-1-4615-4143-1-2.
131. S Zhang, B Lü, GQ Chao, FM Chen, MY Chen, HQ Chen: The effects of milk and milk products on non-steroidal anti-inflammatory drug induced intestinal damage in rats. Zhonghua Nei Ke Za Zhi 50 (9), 771-5 (2011) doi not found.
132. HS Choi, KH Jung, SC Lee, SV Yim, JH Chung, YW Kim, WK Jeon, HP Hong, YG Ko, CH Kim, KH Jang, SA Kang: Bovine colostrum prevents bacterial translocation in an intestinal ischemia/reperfusion-injured rat model. J Med Food 12 (1), 37-46 (2009) DOI: 10.1089/jmf.2007.0613.
133. R Mir, N Singh, G Vikram, RP Kumar, M Sinha, A Bhushan, P Kaur, A Srinivasan, S Sharma, TP Singh: The structural basis for the prevention of nonsteroidal antiinflammatory drug-induced gastrointestinal tract damage by the C-lobe of bovine colostrum lactoferrin. Biophys J 97 (12), 3178-86 (2009) DOI: 10.1016/j.bpj.2009.09.030.
134. JW Kim, WK Jeon, JW Yun, DI Park, YK Cho, IK Sung, CI Sohn, BI Kim, JS Yeom, HS Park, EJ Kim, MS Shin: Protective effects of bovine colostrum on non-steroidal anti-inflammatory drug induced intestinal damage in rats. Asia Pac J Clin Nutr 14 (1), 103-7 (2005) doi not found.
135. EA Reznikov, SS Comstock, C Yi, N Contractor, SM Donovan: Dietary bovine lactoferrin increases intestinal cell proliferation in neonatal piglets. J Nutr 144 (9), 1401-8 (2014) DOI: 10.3945/jn.114.196568.
136. RJ Playford, DN Floyd, CE Macdonald, DP Calnan, RO Adenekan, W Johnson, RA Goodlad, T Marchbank: Bovine colostrum is a health food supplement which prevents NSAID induced gut damage. Gut 44 (5), 653-8 (1999)DOI: 10.1136/gut.44.5.653.
137. RJ Playford, CE MacDonald, DP Calnan, DN Floyd, T Podas, W Johnson, AC Wicks, O Bashir, T Marchbank: Co-Administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability. Clin Sci (Lond) 100 (6), 627-33 (2001) DOI: 10.1042/cs1000627.
138. JW Kim, WK Jeon, EJ Kim: Combined effects of bovine colostrum and glutamine in diclofenac-induced bacterial translocation in rat. Clin Nutr 24 (5), 785-93 (2005) DOI: 10.1016/j.clnu.2005.04.004.
139. NA Feasey, P Healey, MA Gordon: Review article: The aetiology, investigation and management of diarrhoea in the HIV-positive patient. Aliment Pharmacol Ther 34 (6), 587-603 (2011) DOI: 10.1111/j.1365-2036.2011.04781.x.
140. L Elfstrand, CH Flóren: Management of chronic diarrhea in HIV-infected patients: current treatment options, challenges and future directions. HIV AIDS (Auckl) 2, 219-224 (2010) DOI: 10.2147/hiv.s13191.
141. JA Rump, R Arndt, A Arnold, C Bendick, H Dichtelmüller, M Franke, EB Helm, H Jäger, B Kampmann, P Kolb: Treatment of diarrhoea in human immunodeficiency virus-infected patients with immunoglobulins from bovine colostrum. Clin Investig 70 (7), 588-594 (1992) DOI: 10.1007/BF00184800.
142. A Plettenberg, A Stoehr, HJ Stellbrink, H Albrecht, W Meigel: A preparation from bovine colostrum in the treatment of HIV-postive patients with chronic diarrhea. Clin Investig 71 (1), 42-5 (1993) DOI: 10.1007/BF00210962.
143. CH Floren, S Chinenye, L Elfstrand, C Hagman, I Ihse: ColoPlus, a new product based on bovine colostrum, alleviates HIV-Associated diarrhoea. Scand J Gastroenterol 41 (6), 682-6 (2006) DOI: 10.1080/00365520500380817.
144. FO Kaducu, SA Okia, G Upenytho, L Elfstrand, CH Florén: Effect of bovine colostrum-based food supplement in the treatment of HIV-Associated diarrhea in Northern Uganda: A randomized controlled trial. Indian J Gastroenterol 30 (6), 270-6 (2011) DOI: 10.1007/s12664-011-0146-0.
145. J Schmidt, MS Kuhlenschmidt: Microbial adhesion of Cryptosporidium parvum: identification of a colostrum-derived inhibitory lipid. Mol Biochem Parasitol 162 (1), 32-9 (2008) DOI: 10.1016/j.molbiopara.2008.06.016.
146. M Naciri, R Mancassola, JM Reperant, O Canivez, B Quinque, P Yvore: Treatment of experimental ovine cryptosporidiosis with ovine or bovine hyperimmune colostrums. Vet Parasitol 53 (3-4), 173-90 (1994) DOI: 10.1016/0304-4017(94)90181-3.
147. BE Sands: From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology 126 (6), 1518-1532 (2004) DOI: 10.1053/j.gastro.2004.02.072.
148. M Cerquetella, A Spaterna, F Laus, B Tesei, G Rossi, E Antonelli, V Villanacci, G Bassotti: Inflammatory bowel disease in the dog: differences and similarities with humans. World J Gastroenterol 16 (9), 1050-6 (2010) DOI: 10.3748/wjg.v16.i9.1050.
149. T Hisamatsu, T Kanai, Y Mikami, K Yoneno, K Matsuoka, T Hibi: Immune aspects of the pathogenesis of inflammatory bowel disease. Pharmacol Ther 137 (3), 283-97 (2013) DOI: 10.1016/j.pharmthera.2012.10.008.
150. G Bouma, W Strober: The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3 (7), 521-533 (2003) DOI: 10.1152/physrev.00045.2009.
151. I Sekirov, SL Russell, LC Antunes, BB Finlay: Gut microbiota in health and disease. Physiol Rev 90 (3), 859-904 (2010) DOI: 10.1152/physrev.00045.2009.
152. A Andoh, H Imaeda, T Aomatsu, O Inatomi, S Bamba, M Sasaki, Y Saito, T Tsujikawa, Y Fujiyama: Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis. J Gastroenterol 46 (4), 479-86 (2011) DOI: 10.1007/s00535-010-0368-4.
153. A Dignass, JO Lindsay, A Sturm, A Windsor, JF Colombel, M Allez, G D'Haens, A D'Hoore, G Mantzaris, G Novacek, T Oresland, W Reinisch, M Sans, E Stange, S Vermeire, S Travis, G Van Assche: Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J Crohns Colitis 6 (10), 991-1030 (2012) DOI:10.1016/j.crohns.2012.09.002.
154. M Bellavia, F Rappa, M Lo Bello, G Brecchia, G Tomasello, A Leone, G Spatola, ML Uzzo, G Bonaventura, S David, P Damiani, I Hajj Hussein, MN Zeenny, A Jurjus, P Schembri-Wismayer, M Cocchi, G Zummo, F Farina, A Gerbino, F Cappello, G Traina: Lactobacillus casei and bifidobacterium lactis supplementation reduces tissue damage of intestinal mucosa and liver after 2, 4, 6-Trinitrobenzenesulfonic acid treatment in mice. J Biol Regul Homeost Agents 28 (2), 251-61 (2014) doi not found.
155. P Bodammer, C Maletzki, G Waitz, J Emmrich: Prophylactic application of bovine colostrum ameliorates murine colitis via induction of immunoregulatory cells. J Nutr 141 (6), 1056-61 (2011) DOI: 10.3945/jn.110.128702.
156. P Bodammer, E Zirzow, S Klammt, C Maletzki, C Kerkhoff: Alteration of DSS-mediated immune cell redistribution in murine colitis by oral colostral immunoglobulin. BMC Immunol 14, 10-8 (2013) DOI: 10.1186/1471-2172-14-10.
157. Z Khan, C Macdonald, AC Wicks, MP Holt, D Floyd, S Ghosh, NA Wright, RJ Playford: Use of the 'nutriceutical', bovine colostrum, for the treatment of distal colitis: results from an initial study. Aliment Pharmacol Ther 16 (11), 1917-22 (2002) DOI:10.1046/j.1365-2036.2002.01354.x.
158. P Bodammer, C Kerkhoff, C Maletzki, G Lamprecht: Bovine colostrum increases pore-forming claudin-2 protein expression but paradoxically not ion permeability possibly by a change of the intestinal cytokine milieu. PLoS One 8 (5), 64210 (2013) DOI: 10.1371/journal.pone.0064210.
159. M Petrosyan, YS Guner, M Williams, A Grishin, HR Ford: Current concepts regarding the pathogenesis of necrotizing enterocolitis. Pediatric Surgery International 25 (4), 309-18 (2009) DOI: 10.1007/s00383-009-2344-8.
160. RH Siggers, J Siggers, T Thymann, M Boye, PT Sangild: Nutritional modulation of the gut microbiota and immune system in preterm neonates susceptible to necrotizing enterocolitis. J Nutr Biochem 22 (6), 511-21 (2011) DOI: 10.1016/j.jnutbio.2010.08.002.
161. DA Kelly: Intestinal failure-Associated liver disease: what do we know today?. Gastroenterology 130 (2 Suppl 1), 70-7 (2006) DOI: 10.1053/j.gastro.2005.10.066.
162. RJ Xu, F Wang, SH Zhang: Postnatal adaptation of the gastrointestinal tract in neonatal pigs: A possible role of milk-borne growth factors. Livest Prod Sci 66 (2), 95-107 (2000) DOI: 10.1016/S0301-6226(00)00217-7.
163. ER Van Haver, PT Sangild, M Oste, JL Siggers, AL Weyns, CJ Van Ginneken: Diet dependent mucosal colonization and interleukin-1beta responses in preterm pigs susceptible to necrotizing enterocolitis. J Pediatr Gastroenterol Nutr 49 (1), 90-8 (2009) DOI: 10.1097/MPG.0b013e31818de393.
164. MS Cilieborg, M Boye, L Mølbak, T Thymann, PT Sangild: Preterm birth and necrotizing enterocolitis alter gut colonization in pigs. Pediatr Res 69 (1), 10-6 (2011) DOI: 10.1203/PDR.0b013e3181ff2a89.
165. SM Gephart, M Weller: Colostrum as oral immune therapy to promote neonatal health. Adv Neonatal Care 14 (1), 44-51 (2014) DOI: 10.1097/ANC.0000000000000052.
166. MP Sherman, MM Miller, J Sherman, V Niklas: Lactoferrin and necrotizing enterocolitis. Curr Opin Pediatr 26 (2), 146-50 (2014) DOI10.1097/MOP.0000000000000068.
167. Y Li, ML Jensen, DE Chatterton, BB Jensen, T Thymann, AS Kvistgaard, PT Sangild: Raw bovine milk improves gut responses to feeding relative to infant formula in preterm piglets. Am J Physiol Gastrointest Liver Physiol 306 (1), 81-90 (2014) DOI:10.1152/ajpgi.00255.2013.
168. ML Jensen, PT Sangild, M Lykke, M Schmidt, M Boye, BB Jensen, T Thymann: Similar efficacy of human banked milk and bovine colostrum to decrease incidence of necrotizing enterocolitis in preterm piglets. Am J Physiol Regul Integr Comp Physiol 305 (1), 4-12 (2013) DOI: 10.1152/ajpregu.00094.2013.
169. NA Rodriguez, M Vento, EC Claud, CE Wang, MS Caplan: Oropharyngeal administration of mother's colostrum, health outcomes of premature infants: study protocol for a randomized controlled trial. Trials 16 (1), 453-66 (2015) DOI: 10.1186/s13063-015-0969-6.
170. HK Moller, T Thymann, LN Fink, H Frokiaer, AS Kvistgaard, PT Sangild: Bovine colostrum is superior to enriched formulas in stimulating intestinal function and necrotising enterocolitis resistance in preterm pigs. Br J Nutr 105 (1), 44-53 (2011) DOI: 10.1017/S0007114510003168.
171. HJ Brooks, MA McConnell, J Corbett, GS Buchan, CE Fitzpatrick, RS Broadbent: Potential prophylactic value of bovine colostrum in necrotizing enterocolitis in neonates: An in vitro study on bacterial attachment, antibody levels and cytokine production. FEMS Immunol Med Microbiol 48 (3), 347-54 (2006) DOI: 10.1111/j.1574-695X.2006.00151.x.
172. AC Støy, PM Heegaard, T Thymann, M Bjerre, K Skovgaard, M Boye, B Stoll, M Schmidt, BB Jensen, PT Sangild: Bovine colostrum improves intestinal function following formula-induced gut inflammation in preterm pigs. Clin Nutr 33 (2), 322-9 (2014) DOI: 10.1016/j.clnu.2013.05.013.
173. M Pammi, SA Abrams: Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2, CD007137 (2015) DOI:10.1002/14651858.cd007137.pub4.
174. PT Sangild, RH Siggers, M Schmidt, J Elnif, CR Bjornvad, T Thymann, ML Grondahl, AK Hansen, SK Jensen, M Boye, L Moelbak, RK Buddington, BR Weström, JJ Holst, DG Burrin: Diet-And colonization-dependent intestinal dysfunction predisposes to necrotizing enterocolitis in preterm pigs. Gastroenterology 130 (6), 1776-92 (2006) DOI: 10.1053/j.gastro.2006.02.026.
175. J Lee, HS Kim, YH Jung, KY Choi, SH Shin, EK Kim, JH Choi: Oropharyngeal colostrum administration in extremely premature infants: An RCT. Pediatrics 135 (2), 357-66 (2015) DOI: 10.1542/peds.2014-2004.
176. PM Pereira-Fantini, SL Thomas, RG Taylor, E Nagy, M Sourial, PJ Fuller, JE Bines: Colostrum supplementation restores insulin-like growth factor -1 levels and alters muscle morphology following massive small bowel resection. J Parenter Enteral Nutr 32 (3), 266-75 (2008) DOI: 10.1177/0148607108316197.
177. ES Nagy, MC Paris, RG Taylor, PJ Fuller, M Sourial, F Justice, JE Bines: Colostrum protein concentrate enhances intestinal adaptation after massive small bowel resection in juvenile pigs. J Pediatr Gastroenterol Nutr 39 (5), 487-92 (2004) DOI: 10.1097/00005176-200411000-00008.
178. P Lund, PT Sangild, L Aunsholt, B Hartmann, JJ Holst, J Mortensen, PB Mortensen, PB Jeppesen: Randomised controlled trial of colostrum to improve intestinal function in patients with short bowel syndrome. Eur J Clin Nutr 66 (9), 1059-654 (2012) DOI:10.1038/ejcn.2012.93.
179. D Kelly, TP King, M McFadyen, AGP Coutts: Effect of preclosure colostrum intake on the development of the intestinal epithelium of artificially reared piglets. Biol Neonate 64 (4), 235-44 (1993) DOI: 10.1159/000243995.
180. W O'Loughlin, M Winter, A Shun, JA Hardin, DG Gall: Structural and functional adaptation following jejunal resection in rabbits: effect of epidermal growth factor. Gastroenterology 107 (1), 87-93 (1994) doi not found.
181. JW Alexander, ST Boyce, GF Babcock, L Gianotti, MD Peck, DL Dunn, T Pyles, CP Childress, SK Ash: The process of microbial translocation. Ann Surg 212 (4), 496-510 (1990) DOI: 10.1097/00000658-199010000-00012.
182. H Tsujimoto, S Ono, H Mochizuki: Role of translocation of pathogen-Associated molecular patterns in sepsis. Dig Surg 26 (2), 100-9 (2009) DOI: 10.1159/000206143.
183. E Bolke, PM Jehle, F Hausmann, A Däubler, H Wiedeck, G Steinbach, M Storck, K Orth: Preoperative oral application of immunoglobulin- enriched colostrum milk and mediator response during abdominal surgery. Shock 17 (1), 9-12 (2002) DOI: 10.1097/00024382-200201000-00002.
184. E Bolke, K Orth, PM Jehle, A Schwarz, G Steinbach, S Schleich, C Ulmer, M Storck, A Hannekum: Enteral application of an immunoglobulin-enriched colostrum milk preparation for reducing endotoxin translocation and acute phase response in patients undergoing coronary bypass surgery -A randomized placebo controlled pilot trial. Wien Klin Wochenschr 114 (21-22), 923-8 (2002) doi not found.
185. JR Döhler, L Nebermann: Bovine colostrum in oral treatment of enterogenic endotoxaemia in rats. Crit Care 6 (6), 536-9 (2002) DOI: 10.1186/cc1819.
186. LL Go, CT Albanese, SC Watkins, RL Simmons, MI Rowe: Breast milk protects the neonate from bacterial translocation. J Pediatr Surg 29 (8), 1059-63 (1994) DOI: 10.1016/0022-3468(94)90279-8.
187. R Lissner, H Schmidt, H Karch: A standard immunoglobulin preparation produced from bovine colostra shows antibody reactivity and neutralization activity against Shiga-like toxins and EHEC-hemolysin of Escherischia coli 0157:H7. Infection 24 (5), 378-383 (1996) DOI: 10.1007/BF01716084.
188. AY Kshirsagar, MA Vekariya, V Gupta, AS Pednekar, A Mahna, R Patankar, A Shaikh, B Nagur: A comparative study of colostrum dressing versus conventional dressing in deep wounds. J Clin Diagn Res 9 (4), 1-4 (2015) DOI: 10.7860/jcdr/2015/12004.5739.
189. PF Davis, NS Greenhill, AM Rowan, LM Schollum: The safety of New Zealand bovine colostrum: Nutritional and physiological evaluation in rats. Food Chem Toxicol 45 (2), 229-36 (2007) DOI: 10.1016/j.fct.2006.07.034.
190. WG Struff, G Sprotte: Bovine colostrum as a biologic in clinical medicine: A review - Part II: clinical studies. Int J Clin Pharmacol Ther 46 (5), 211-225 (2008) DOI10.5414/CPP46211.
191. S Tsabouri, K Douros, KN Priftis: Cow's milk allergenicity. Endocr Metab Immune Disord Drug Targets 14 (1), 16-26 (2014)DOI: 10.2174/1871530314666140121144224.